Streetbeat News

Analyst Ratings

CENTA

Analysts predict that Central Garden (CENTA) will report a decline in earnings in its upcoming report. The company lacks the necessary factors to likely exceed earnings expectations.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

VERA

Wall Street analysts suggest a potential 27.3% upside for Vera Therapeutics (VERA) based on consensus price targets. Despite skepticism about the effectiveness of price targets, positive earnings estimate revisions could indicate a near-term stock price increase.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

THRD

Wall Street analysts have set an average price target for Third Harmonic Bio, Inc. (THRD) that suggests a potential upside of 26.7%. This optimism is supported by positive trends in earnings estimate revisions.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

BUR

Wall Street analysts have set a mean price target for Burford Capital (BUR) that suggests a potential 42.6% upside. Despite the historical inaccuracy of such metrics, the consensus among analysts in raising earnings estimates supports a positive outlook for BUR.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

STRA

Wall Street analysts suggest a 26.8% upside potential for Strategic Education (STRA), driven by an upward trend in earnings estimate revisions.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

PBAM

Analysts predict a 29.3% upside for Private Bancorp of America (PBAM) based on price targets and raised earnings estimates.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

HAE

Wall Street analysts predict a potential 25.6% upside for Haemonetics (HAE) stock, based on the mean of analysts' price targets. Despite the mixed reliability of this metric, the consensus on raising earnings estimates suggests a positive outlook.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

ARQT

Wall Street analysts have set a consensus price target for Arcutis Biotherapeutics (ARQT), indicating a potential 70.3% upside. Despite skepticism about the effectiveness of price targets, positive earnings estimate revisions suggest a possible near-term stock price increase.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

TSLA

Wedbush analysts have increased their price target for Tesla Inc (NASDAQ:TSLA) from $300 to $400, maintaining an 'Outperform' rating. They believe that a friendlier regulatory environment under Donald Trump's presidency will benefit Tesla's AI initiatives.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

SFM

Sprouts Farmers Market (SFM) is highlighted as a strong growth stock according to Zacks Style Scores, a feature of the Zacks Premium research service.

Portfolio Pulse from

November 11, 2024 | 4:00 pm